Vindoline Exhibits Anti-Diabetic Potential in Insulin-Resistant 3T3-L1 Adipocytes and L6 Skeletal Myoblasts
Nutrients · 2023
DOI: 10.3390/nu15132865 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2023. Verfasst von Beegum Noorjahan Shijina und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, University of Kerala, Kariavattom Campus, Thiruvananthapuram 695581, Kerala, India. Hauptthemen laut MEDLINE: Insulin Resistance, Diabetes Mellitus, Type 2, Myoblasts, Skeletal. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Kerala, University Grants Commission, India, Senior Research Fellowship from University Grants Commission, India.
Abstract (Originalsprache)
Type 2 diabetes mellitus (T2DM) emerged as a major health care concern in modern society, primarily due to lifestyle changes and dietary habits. Obesity-induced insulin resistance is considered as the major pathogenic factor in T2DM. In this study, we investigated the effect of vindoline, an indole alkaloid of Catharanthus roseus on insulin resistance (IR), oxidative stress and inflammatory responses in dexamethasone (IR inducer)-induced dysfunctional 3T3-L1 adipocytes and high-glucose-induced insulin-resistant L6-myoblast cells. Results showed that dexamethasone-induced dysfunctional 3T3-L1 adipocytes treated with different concentrations of vindoline significantly enhanced basal glucose consumption, accompanied by increased expression of GLUT-4, IRS-1 and adiponectin. Similarly, vindoline-treated insulin-resistant L6 myoblasts exhibited significantly enhanced glycogen content accompanied with upregulation of IRS-1 and GLUT-4. Thus, in vitro studies of vindoline in insulin resistant skeleton muscle and dysfunctional adipocytes confirmed that vindoline treatment significantly mitigated insulin resistance in myotubes and improved functional status of adipocytes. These results demonstrated that vindoline has the potential to be used as a therapeutic agent to ameliorate obesity-induced T2DM-associated insulin resistance profile in adipocytes and skeletal muscles.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, University of Kerala, Kariavattom Campus, Thiruvananthapuram 695581, Kerala, India.
- Department of Biochemistry, Government College, Kariavattom, Thiruvananthapuram 695581, Kerala, India.
- Department of Biochemistry, PMS College of Dental Science and Research, Vattappara, Thiruvananthapuram 695028, Kerala, India.
ORCID-Profile: Prabath Gopalakrishnan Biju
Förderung
- University of Kerala
- University Grants Commission, India
- Senior Research Fellowship from University Grants Commission, India
- University of Kerala plan fund
Zitieren
APA
Shijina, B. N., Radhika, A., Sherin, S., & Biju, P. G. (2023). Vindoline Exhibits Anti-Diabetic Potential in Insulin-Resistant 3T3-L1 Adipocytes and L6 Skeletal Myoblasts. Nutrients. https://doi.org/10.3390/nu15132865
Vancouver
Shijina BN, Radhika A, Sherin S, Biju PG. Vindoline Exhibits Anti-Diabetic Potential in Insulin-Resistant 3T3-L1 Adipocytes and L6 Skeletal Myoblasts. Nutrients. 2023. doi:10.3390/nu15132865
BibTeX
@article{Shijina2023,
author = {Shijina, Beegum Noorjahan and Radhika, Achuthan and Sherin, Sainulabdeen and Biju, Prabath Gopalakrishnan},
title = {Vindoline Exhibits Anti-Diabetic Potential in Insulin-Resistant 3T3-L1 Adipocytes and L6 Skeletal Myoblasts},
journal = {Nutrients},
year = {2023},
doi = {10.3390/nu15132865}
}
EUVIMED